Genetic evaluation of suspected cases of transient HIV-1 infection of infants

Science

Volumn 280, Issue 5366, 1998, Pages 1073-1077

  Frenkel, Lisa M ^a,b   Mullins, James I ^c   Learn, Gerald H ^c   Manns Arcuino, Laura ^b   Herring, Belinda L ^c   Kalish, Marcia L ^d   Steketee, Richard W ^d   Thea, Donald M ^e   Nichols, Joan E ^a,f   Liu, Shan Lu ^c   Harmache, Abdallah ^c   He, Xi ^c   Muthui, David ^c   Madan, Anup ^c   Hood, Leroy ^c   Haase, Ashley T ^g   Zupancic, Mary ^g   Staskus, Katherine ^g   Wolinsky, Steven ^h   Krogstad, Paul ⁱ   Zhao, JiaQi ⁱ   Chen, Irvin ⁱ   Koup, Richard ^j   Ho, David ^j   Korber, Bette ^k   Apple, Raymond J ^l   Coombs, Robert W ^c   Pahwa, Savita ^m   Roberts Jr , Norbert J ^f,n   more..

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e Medical and Health Research Association of New York City Inc   (United States)

^f UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^g UNIVERSITY OF MINNESOTA   (United States)

^h NORTHWESTERN UNIVERSITY   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j AARON DIAMOND AIDS RESEARCH CENTER   (United States)

^k Sante Fe Institute   (United States)

^l Roche Molecular Diagnostics   (United States)

^m NORTH SHORE UNIVERSITY HOSPITAL   (United States)

ⁿ UNIVERSITY OF ROCHESTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INFANT; INFANT DISEASE; NEWBORN; NUCLEOTIDE SEQUENCE; PATIENT SATISFACTION; PERINATAL CARE; PHYLOGENY; PRIORITY JOURNAL; VIRUS DETECTION;

DIAGNOSTIC ERRORS; DISEASE TRANSMISSION, VERTICAL; DNA, VIRAL; EQUIPMENT CONTAMINATION; FEMALE; GENES, ENV; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; MOLECULAR SEQUENCE DATA; PHYLOGENY; POLYMERASE CHAIN REACTION; RNA, VIRAL; SPECIMEN HANDLING; T-LYMPHOCYTES, CYTOTOXIC; VIREMIA;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0032524738     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.280.5366.1073     Document Type: Article

References (33)

1. Y. J. Bryson et al., N. Engl. J. Med. 332, 833 (1995).
2. S. S. Bakshi, S. Tetali, E. J. Abrams, M. O. Paul, S. G. Pahwa, Pediatr. Infect. Dis. J. 14, 658 (1995).
3. P. A. Roques et al., AIDS 1995 9, F19 (1995).
4. W. Borkowsky, K. Krasinski, T. Moore, V. Papaevangelou, AIDS Res. Hum. Retroviruses 6, 673 (1990); M. Clerici et al., J. Infect. Dis. 165, 1012 (1992); R. Cheynier et al., Eur. J. Immunol. 22, 2211 (1992); M. Clerici et al., AIDS 7, 1427 (1993); S. L. Rowland-Jones et al., Lancet 341, 860 (1993); S. L. Rowland-Jones et al., Nature Med. 1, 59 (1995); M. Clerici et al., JAMA 271, 42 (1994); A. De Maria, C. Cirillo, L. Moretta, J. Infect. Dis. 170, 1296 (1994).
5. W. Borkowsky, K. Krasinski, T. Moore, V. Papaevangelou, AIDS Res. Hum. Retroviruses 6, 673 (1990); M. Clerici et al., J. Infect. Dis. 165, 1012 (1992); R. Cheynier et al., Eur. J. Immunol. 22, 2211 (1992); M. Clerici et al., AIDS 7, 1427 (1993); S. L. Rowland-Jones et al., Lancet 341, 860 (1993); S. L. Rowland-Jones et al., Nature Med. 1, 59 (1995); M. Clerici et al., JAMA 271, 42 (1994); A. De Maria, C. Cirillo, L. Moretta, J. Infect. Dis. 170, 1296 (1994).
6. W. Borkowsky, K. Krasinski, T. Moore, V. Papaevangelou, AIDS Res. Hum. Retroviruses 6, 673 (1990); M. Clerici et al., J. Infect. Dis. 165, 1012 (1992); R. Cheynier et al., Eur. J. Immunol. 22, 2211 (1992); M. Clerici et al., AIDS 7, 1427 (1993); S. L. Rowland-Jones et al., Lancet 341, 860 (1993); S. L. Rowland-Jones et al., Nature Med. 1, 59 (1995); M. Clerici et al., JAMA 271, 42 (1994); A. De Maria, C. Cirillo, L. Moretta, J. Infect. Dis. 170, 1296 (1994).
7. W. Borkowsky, K. Krasinski, T. Moore, V. Papaevangelou, AIDS Res. Hum. Retroviruses 6, 673 (1990); M. Clerici et al., J. Infect. Dis. 165, 1012 (1992); R. Cheynier et al., Eur. J. Immunol. 22, 2211 (1992); M. Clerici et al., AIDS 7, 1427 (1993); S. L. Rowland-Jones et al., Lancet 341, 860 (1993); S. L. Rowland-Jones et al., Nature Med. 1, 59 (1995); M. Clerici et al., JAMA 271, 42 (1994); A. De Maria, C. Cirillo, L. Moretta, J. Infect. Dis. 170, 1296 (1994).
8. W. Borkowsky, K. Krasinski, T. Moore, V. Papaevangelou, AIDS Res. Hum. Retroviruses 6, 673 (1990); M. Clerici et al., J. Infect. Dis. 165, 1012 (1992); R. Cheynier et al., Eur. J. Immunol. 22, 2211 (1992); M. Clerici et al., AIDS 7, 1427 (1993); S. L. Rowland-Jones et al., Lancet 341, 860 (1993); S. L. Rowland-Jones et al., Nature Med. 1, 59 (1995); M. Clerici et al., JAMA 271, 42 (1994); A. De Maria, C. Cirillo, L. Moretta, J. Infect. Dis. 170, 1296 (1994).
9. W. Borkowsky, K. Krasinski, T. Moore, V. Papaevangelou, AIDS Res. Hum. Retroviruses 6, 673 (1990); M. Clerici et al., J. Infect. Dis. 165, 1012 (1992); R. Cheynier et al., Eur. J. Immunol. 22, 2211 (1992); M. Clerici et al., AIDS 7, 1427 (1993); S. L. Rowland-Jones et al., Lancet 341, 860 (1993); S. L. Rowland-Jones et al., Nature Med. 1, 59 (1995); M. Clerici et al., JAMA 271, 42 (1994); A. De Maria, C. Cirillo, L. Moretta, J. Infect. Dis. 170, 1296 (1994).
10. W. Borkowsky, K. Krasinski, T. Moore, V. Papaevangelou, AIDS Res. Hum. Retroviruses 6, 673 (1990); M. Clerici et al., J. Infect. Dis. 165, 1012 (1992); R. Cheynier et al., Eur. J. Immunol. 22, 2211 (1992); M. Clerici et al., AIDS 7, 1427 (1993); S. L. Rowland-Jones et al., Lancet 341, 860 (1993); S. L. Rowland-Jones et al., Nature Med. 1, 59 (1995); M. Clerici et al., JAMA 271, 42 (1994); A. De Maria, C. Cirillo, L. Moretta, J. Infect. Dis. 170, 1296 (1994).
11. W. Borkowsky, K. Krasinski, T. Moore, V. Papaevangelou, AIDS Res. Hum. Retroviruses 6, 673 (1990); M. Clerici et al., J. Infect. Dis. 165, 1012 (1992); R. Cheynier et al., Eur. J. Immunol. 22, 2211 (1992); M. Clerici et al., AIDS 7, 1427 (1993); S. L. Rowland-Jones et al., Lancet 341, 860 (1993); S. L. Rowland-Jones et al., Nature Med. 1, 59 (1995); M. Clerici et al., JAMA 271, 42 (1994); A. De Maria, C. Cirillo, L. Moretta, J. Infect. Dis. 170, 1296 (1994).
12. M. O. McClure et al., Nature 375, 637 (1995).
13. E. M. Connor and L. M. Mofenson, Pediatr. Infect. Dis. J. 14, 536 (1995).
14. R. W. Steketee et al., J. Infect. Dis. 175, 707 (1997).
15. Y. Cao et al., Nature Med. 3, 549 (1997).
16. L. M. Frenkel et al., Clin. Infect. Dis. 20, 1321 (1995). Reaction conditions plus a detailed list of PCR primers covering the gag, pol, and env regions used for assessing HIV-1 infection are provided in (12). For phylogenetic analysis, a 650-base pair (bp) region of HIV-1 env, corresponding to the V3 through V5 region, was amplified by nPCR with primers ED5/12 and ES7/8 [E. L. Delwart et al., Science 262, 1257 (1993)] and cloned into plasmids. Four to six clones from each specimen were sequenced. In the case of the CDC specimens, direct sequencing of 345 bp of the V3 and flanking regions was done as previously described [H. W. Jaffe et al., Ann. Intern. Med. 121, 855 (1994)].
17. L. M. Frenkel et al., Clin. Infect. Dis. 20, 1321 (1995). Reaction conditions plus a detailed list of PCR primers covering the gag, pol, and env regions used for assessing HIV-1 infection are provided in (12). For phylogenetic analysis, a 650-base pair (bp) region of HIV-1 env, corresponding to the V3 through V5 region, was amplified by nPCR with primers ED5/12 and ES7/8 [E. L. Delwart et al., Science 262, 1257 (1993)] and cloned into plasmids. Four to six clones from each specimen were sequenced. In the case of the CDC specimens, direct sequencing of 345 bp of the V3 and flanking regions was done as previously described [H. W. Jaffe et al., Ann. Intern. Med. 121, 855 (1994)].
18. L. M. Frenkel et al., Clin. Infect. Dis. 20, 1321 (1995). Reaction conditions plus a detailed list of PCR primers covering the gag, pol, and env regions used for assessing HIV-1 infection are provided in (12). For phylogenetic analysis, a 650-base pair (bp) region of HIV-1 env, corresponding to the V3 through V5 region, was amplified by nPCR with primers ED5/12 and ES7/8 [E. L. Delwart et al., Science 262, 1257 (1993)] and cloned into plasmids. Four to six clones from each specimen were sequenced. In the case of the CDC specimens, direct sequencing of 345 bp of the V3 and flanking regions was done as previously described [H. W. Jaffe et al., Ann. Intern. Med. 121, 855 (1994)].
19. Independently segregating loci or the HLA-DQa locus were used to evaluate the identity of patient specimens. The former included HLA-DQA1, low-density lipoprotein receptor, glycophorin A, hemoglobin G gammaglobin, D7S8, and a group-specific component (GC) (AmpliType PM PCR Amplification and Typing Kit, Perkin-Elmer, Foster City, CA). The combined power of discrimination for these six markers for Caucasians in the United States is 0.9997. Discordance of the HLA-DQA1 loci (Amplitype HLA DQa Amplification and Typing Kit, Perkin-Elmer) among the CDC infant's specimens was taken to indicate specimen mislabeling. When an infant's specimens had concordant HLA-DQa loci, the env sequences in each specimen were examined by phylogenetic analysis.
20. The methods described by G. H. Learn et al. [J. Virol. 70, 5720 (1996)] were used to align DNA sequences (with the use of CLUSTALW plus manual adjustment), calculate genetic distances (with the use of DNADIST, using the maximum likelihood method), evaluate potential sample mixups, construct neighbor joining trees, and perform bootstrap analyses (1000 replicates). Sequence regions that could not be unambiguously aligned were removed from subsequent analyses. Each sequence was compared for phylogenetic relatedness to the entire set of published and available unpublished laboratory HIV database sequences. If after this analysis the viral sequences from a mother and an infant appeared as a monophyletic group on a phylogenetic tree, they were judged to be phylogenetically linked or to have a common ancestor not shared by sequences from any other individuals evaluated. Issues regarding the assignment of phylogenetic linkage are discussed in greater detail by Learn et al.
21. L. M. Frenkel et al., at www.sciencemag.org/feature/ data/974996.shl.
22. R. Liu et al., Cell 86, 367 (1996).
23. L. M. Frenkel et al., unpublished data.
24. M.-L. Newell et al., Lancet 347, 213 (1996).
25. P. Palumbo, J. Skurnick, D. Lewis, M. Eisenberg, J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 10, 436 (1995).
26. A. McMichael, R. Koup, A. J. Ammann, N. Eng. J. Med. 334, 801 (1996).
27. E. C. Holmes et al., J. Infect. Dis. 167, 1411 (1993).
28. T. Liu et al., J. Immunol. 154, 3147 (1995).
29. A. Hoffenbach et al., ibid. 142, 452 (1989).
30. G. Schochetman, S. Subbarao, M. L. Kalish, in Viral Genome Methods, K. W. Adolph, Ed. (CRC Press, Boca Raton, FL, 1996), pp. 25-41.
31. E. L. Delwart, M. P. Busch, M. L. Kalish, J. W. Mosley, J. I. Mullins, AIDS Res. Hum. Retrovir. 11, 1181 (1995).
32. C. H. Contag et al., J. Virol. 71, 1292 (1997).
33. We thank J. Conroy for performing PCR assays; E. Abrams, M. S. Ortoff, R. C. Reichman, L. M. Demeter, J. S. Lambert, R. Dolin, R. Sperling, D. Shapiro, G. McSherry, and the Ariel Project and ACTG 076 investigators for critical patient specimens; D. Swofford for use of computer program PAUP*, version 4.0.0d63; and C. B. Wilson and K. K. Holmes for editorial contributions. This work was supported by grants from the Pediatric AIDS Foundation (500153-10-PGT, 50366-14-PGR, 55516-ARI, 55529-ARI, 55525-ARI, 55532-ARI, 55526-ARI, 55531-ARI, and 55522-ARI), the U.S. Public Health Service (UO1-27658, Al32910, Al27757, and Al35539), and the Foster Foundation.